Patents by Inventor Jiao YIN

Jiao YIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Display Modules with Direct-lit Backlight Units
    Publication number: 20240126120
    Abstract: A display may have a pixel array such as a liquid crystal pixel array. The pixel array may be illuminated with backlight illumination from a direct-lit backlight unit. The backlight unit may include an array of light-emitting diodes (LEDs) on a printed circuit board. The display may have a notch to accommodate an input-output component. Reflective layers may be included in the notch. The backlight may include a color conversion layer with a property that varies as a function of position. The light-emitting diodes may be covered by a slab of encapsulant with recesses in an upper surface.
    Type: Application
    Filed: December 8, 2023
    Publication date: April 18, 2024
    Inventors: Meizi Jiao, Joshua A. Spechler, Jie Xiang, Zhenyue Luo, Chungjae Lee, Morteza Amoorezaei, Mengyang Liang, Xinyu Zhu, Mingxia Gu, Jun Qi, Eric L. Benson, Victor H. Yin, Youchul Jeong, Xiang Fang, Yanming Li, Michael J. Lee, Marianna C. Sbordone, Ari P. Miller, Edward J. Cooper, Michael C. Sulkis, Francesco Ferretti, Seth G. McFarland, Mary M. Morrison, Eric N. Vergo, Terence Chan, Ian A. Guy, Keith J. Hendren, Sunitha Chandra
  • USE OF TM9SF1 GENE AS TARGET IN VASCULAR DISEASES
    Publication number: 20200340055
    Abstract: The present disclosure discloses use of TM9SF1 gene as a target in vascular diseases, which relates to the field of biotechnology. In the present disclosure, by means of RNA interference strategy, it is found that after endogenous TM9SF1 gene is interfered with, the expression of two important genes IL1? and IL8 related to the inflammation of HUVEC and the expression of the gene ACE1 closely related to vasoconstriction are remarkably downregulated, suggesting that TM9SF1 gene has positive regulation effect on the expression of IL1?, IL8 and ACE1 genes. By inhibiting or silencing the expression of the TM9SF1 gene, it is possible to inhibit or silence the expression of IL1?, IL8, and ACE1 genes, and further achieve the object of treating or preventing vascular diseases associated with the expression level of IL1?, IL8 and ACE1 genes.
    Type: Application
    Filed: July 16, 2018
    Publication date: October 29, 2020
    Inventors: Juan XIAO, Yanli HUANG, Chun MAO, Lin YANG, Jiao YIN, Xiaoming HE, Xiaofang SHEN, Wenbin DENG, Yuntao WU